FLEX FIRST Registry Research Protocol
Sponsor: VentureMed Group Inc.
Listed as NCT05616104, this observational or N/A phase trial focuses on Arterial Occlusive Diseases and Arteriovenous Fistula and remains completed. Sponsored by VentureMed Group Inc., it has been updated 10 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Dec 2024 — Apr 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
May 2023 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — May 2023 [monthly]
Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Recruiting
-
Jan 2023 — Feb 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2022 — Jan 2023 [monthly]
Not Yet Recruiting
First recorded
Nov 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VentureMed Group Inc.
For direct contact, visit the study record on ClinicalTrials.gov .